AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
24 Jul 2020 07:00 AM
RNS
Breztri Aerosphere approved in the US for COPD
22 Jul 2020 03:00 PM
RNS
Holding(s) in Company
22 Jul 2020 03:00 PM
RNS
Holding(s) in Company
21 Jul 2020 03:00 PM
RNS
Holding(s) in Company
21 Jul 2020 03:00 PM
RNS
Holding(s) in Company
20 Jul 2020 02:41 PM
RNS
COVID-19 vaccine Phase I/II showed immune response
16 Jul 2020 07:00 AM
RNS
Director Declaration
09 Jul 2020 07:00 AM
RNS
Brilinta granted US FDA Priority Review for stroke
08 Jul 2020 07:00 AM
RNS
Lynparza approved in the EU for pancreatic cancer
01 Jul 2020 03:00 PM
RNS
Total Voting Rights
30 Jun 2020 03:00 PM
RNS
Director/PDMR Shareholding
30 Jun 2020 07:00 AM
RNS
Selumetinib granted Japan orphan drug designation
17 Jun 2020 03:03 PM
RNS
Holding(s) in Company
17 Jun 2020 03:00 PM
RNS
Holding(s) in Company
15 Jun 2020 07:00 AM
RNS
Agreement to Supply Europe with COVID-19 Vaccine
11 Jun 2020 07:00 AM
RNS
EMTN Programme Routine Technical Update
01 Jun 2020 03:00 PM
RNS
Total Voting Rights
01 Jun 2020 03:00 PM
RNS
Block listing Interim Review
01 Jun 2020 07:00 AM
RNS
Brilinta obtains additional US approval
01 Jun 2020 07:00 AM
RNS
Lynparza EU CHMP opinion in pancreatic cancer
29 May 2020 04:41 PM
RNS
Second Price Monitoring Extn
29 May 2020 04:35 PM
RNS
Price Monitoring Extension
29 May 2020 01:00 PM
RNS
Enhertu DESTINY-Gastric01 results from ASCO 2020
29 May 2020 01:00 PM
RNS
Imfinzi sustained overall survival in CASPIAN
29 May 2020 07:00 AM
RNS
Tagrisso unprecedented adjuvant lung cancer data
26 May 2020 10:30 AM
RNS
Director/PDMR Shareholding
22 May 2020 07:00 AM
RNS
Enhertu US orphan designation in gastric cancer
21 May 2020 07:00 AM
RNS
AstraZeneca advances response to COVID-19 outbreak
20 May 2020 07:00 AM
RNS
Lynparza approved in the US for prostate cancer
18 May 2020 07:00 AM
RNS
Enhertu US Breakthrough status for lung cancer
18 May 2020 07:00 AM
RNS
Bevespi Aerosphere approved in China for COPD
11 May 2020 07:00 AM
RNS
Enhertu designated gastric cancer BTD
11 May 2020 07:00 AM
RNS
Brazikumab rights recovered by AstraZeneca
11 May 2020 07:00 AM
RNS
Lynparza gets broader US ovarian cancer approval
06 May 2020 07:00 AM
RNS
Farxiga approved by FDA for heart failure (HFrEF)
01 May 2020 03:00 PM
RNS
Total Voting Rights
29 Apr 2020 04:00 PM
RNS
Result of AGM
29 Apr 2020 07:00 AM
RNS
AZN: first-quarter 2020 results
24 Apr 2020 07:00 AM
RNS
Lynparza shows overall survival in prostate cancer
17 Apr 2020 11:00 AM
RNS
Changes to arrangements for AGM
14 Apr 2020 07:00 AM
RNS
Koselugo (selumetinib) approved in the US for NF1
14 Apr 2020 07:00 AM
RNS
Tagrisso adjuvant trial overwhelmingly positive
02 Apr 2020 07:00 AM
RNS
AstraZeneca divestment of Movantik completed
01 Apr 2020 03:00 PM
RNS
Total Voting Rights
31 Mar 2020 07:00 AM
RNS
Director/PDMR Shareholding
30 Mar 2020 07:01 AM
RNS
Imfinzi approved in US for small cell lung cancer
30 Mar 2020 07:00 AM
RNS
Farxiga CKD trial early stop for positive efficacy
26 Mar 2020 07:00 AM
RNS
Director/PDMR Shareholding
26 Mar 2020 07:00 AM
RNS
Lokelma approved in Japan for hyperkalaemia
24 Mar 2020 04:41 PM
RNS
Second Price Monitoring Extn
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings